🔎 Trials Near Me

Akèy › Lukemi lenfositè kwonik › Main

Etid klinik pou Lukemi lenfositè kwonik nan Main

6 etid pou Lukemi lenfositè kwonik ap chèche patisipan nan sit nan Main.

Vil nan Main

Tèks ofisyèl etid la (Anglè)

Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL

  • MaineHealth Maine Medical Center - Portland, Portland
  • MaineHealth Cancer Care and IV Therapy - South Portland, South Portland
Ap rekriteFaz 3
Laj 65 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT07321652

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • Harold Alfond Center for Cancer Care, Augusta
  • MaineHealth Waldo Hospital, Belfast
  • Lafayette Family Cancer Center-EMMC, Brewer
  • ak 9 plis
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 40 a 75 · Tout sèks · Mizajou Oct 2, 2026 · NCT05334069

Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study

  • Harold Alfond Center for Cancer Care, Augusta
  • MaineHealth Cancer Care and IV Therapy - Brunswick, Brunswick
  • Mid Coast Hospital, Brunswick
  • ak 4 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT04269902

Fixed Duration Pirtobrutinib and Obinutuzumab in Chronic Lymphocytic Leukemia

  • New England Cancer Specialists, Scarborough
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jan 21, 2026 · NCT06333262

Zanubrutinib and Venetoclax in CLL (ZANU-VEN)

  • New England Cancer Specialists, Scarborough
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Dec 5, 2025 · NCT05168930

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.